tiprankstipranks
Albireo Pharma downgraded to Market Perform from Outperform at Cowen
PremiumThe FlyAlbireo Pharma downgraded to Market Perform from Outperform at Cowen
1y ago
Albireo Pharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Albireo Pharma downgraded to Neutral from Buy at H.C. Wainwright
1y ago
Albireo Sells Out to Ipsen
PremiumMarket News
Albireo Sells Out to Ipsen
1y ago
Albireo Submits Bylvay® Alagille Syndrome Regulatory Filings to FDA and EMA
PremiumPress ReleasesAlbireo Submits Bylvay® Alagille Syndrome Regulatory Filings to FDA and EMA
1y ago
Albireo Pharma submits regulatory filings to FDA, EMA for Bylvay in ALGS
PremiumThe Fly
Albireo Pharma submits regulatory filings to FDA, EMA for Bylvay in ALGS
1y ago
Albireo Pharma participates in a conference call with William Blair
PremiumThe Fly
Albireo Pharma participates in a conference call with William Blair
1y ago
Albireo Appoints Paul Streck, M.D., as Chief Medical Officer & Craig Hopkinson, M.D., to Board of Directors
PremiumPress ReleasesAlbireo Appoints Paul Streck, M.D., as Chief Medical Officer & Craig Hopkinson, M.D., to Board of Directors
1y ago
Albireo to Participate in Jefferies London Healthcare Conference
PremiumPress Releases
Albireo to Participate in Jefferies London Healthcare Conference
1y ago
Albireo Reports Q3 2022 Financial Results and Business Update
PremiumPress Releases
Albireo Reports Q3 2022 Financial Results and Business Update
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100